por
Peluso, Michael J.,
Takahashi, Saki,
Hakim, Jill,
Kelly, J. Daniel,
Torres, Leonel,
Iyer, Nikita S.,
Turcios, Keirstinne,
Janson, Owen,
Munter, Sadie E.,
Thanh, Cassandra,
Nixon, Christopher C.,
Hoh, Rebecca,
Tai, Viva,
Fehrman, Emily A.,
Hernandez, Yanel,
Spinelli, Matthew A.,
Gandhi, Monica,
Palafox, Mary-Ann,
Vallari, Ana,
Rodgers, Mary A.,
Prostko, John,
Hackett, John,
Trinh, Lan,
Wrin, Terri,
Petroplolous, Christos J.,
Chiu, Charles Y.,
Norris, Philip J.,
DiGermanio, Clara,
Stone, Mars,
Busch, Michael P.,
Elledge, Susanna K.,
Zhou, Xin X.,
Wells, James A.,
Shu, Albert,
Kurtz, Theodore W.,
Pak, John E.,
Wu, Wesley,
Burbelo, Peter D.,
Cohen, Jeffrey I.,
Rutishauser, Rachel L.,
Martin, Jeffrey N.,
Deeks, Steven G.,
Henrich, Timothy J.,
Rodriguez-Barraquer, Isabel,
Greenhouse, Bryan
Publicado 2021
“…Variations in sensitivity and durability were particularly dramatic for individuals with mild infection, who had consistently lower antibody titers and represent the majority of the infected population, with sensitivities often differing substantially from reported test characteristics (e.g., amongst commercial assays, sensitivity at 6 months ranged from 33% for
ARCHITECT IgG to 98% for VITROS Total Ig). Thus, the ability to detect previous infection by SARS-CoV-2 is highly dependent on the severity of the initial infection, timing relative to infection, and the assay used. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto
